| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-11 18:06 Tx date 2025-03-06 |
$TELO
Telo Genomics Corp. |
Ross, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,500
+150,000 vol $0.15 each |
250,000 | |
| Filed 2025-03-11 18:04 Tx date 2025-03-06 |
$TELO
Telo Genomics Corp. |
Rogers, Hugh
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$52,500
+350,000 vol $0.15 each |
650,000 | |
| Filed 2025-03-11 18:03 Tx date 2025-03-06 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
1,280,752 | |
| Filed 2025-03-11 18:01 Tx date 2025-03-06 |
$TELO
Telo Genomics Corp. |
Baechler, Guido
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$150,000
+1,000,000 vol $0.15 each |
1,700,000 | |
| Filed 2025-01-03 18:37 Tx date 2024-12-30 |
$TELO
Telo Genomics Corp. |
Baechler, Guido
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+150,000 vol |
150,000 | |
| Filed 2025-01-03 18:36 Tx date 2019-02-28 |
$TELO
Telo Genomics Corp. |
Baechler, Guido
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-01-03 18:36 Tx date 2024-12-30 |
$TELO
Telo Genomics Corp. |
Baechler, Guido
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,000
+150,000 vol $0.10 each |
150,000 | |
| Filed 2025-01-03 18:34 Tx date 2019-02-28 |
$TELO
Telo Genomics Corp. |
Baechler, Guido
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-11 13:43 Tx date 2023-12-08 |
$TELO
Telo Genomics Corp. |
Mai, Sabine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
780,752 | |
| Filed 2023-03-09 18:40 Tx date 2023-03-07 |
$TELO
Telo Genomics Corp. |
Weinberg, Kristan Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,000
+80,000 vol $0.30 each |
80,000 | |
| Filed 2023-01-10 19:50 Tx date 2022-12-30 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$60,000
+400,000 vol $0.15 each |
1,450,000 | |
| Filed 2023-01-10 19:49 Tx date 2022-12-30 |
$TELO
Telo Genomics Corp. |
Louis, Sherif
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-60,000
-400,000 vol $0.15 each |
104,000 | |
| Filed 2022-12-13 21:12 Tx date 2022-12-12 |
$TELO
Telo Genomics Corp. |
Weinberg, Kristan Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$350,000
+1,000,000 vol $0.35 each |
1,000,000 | |
| Filed 2022-12-13 21:11 Tx date 2022-12-12 |
$TELO
Telo Genomics Corp. |
Weinberg, Kristan Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-13 21:11 Tx date 2022-12-12 |
$TELO
Telo Genomics Corp. |
Weinberg, Kristan Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-21 14:19 Tx date 2022-03-15 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$83,750
+250,000 vol $0.335 each |
250,000 | |
| Filed 2022-03-17 17:30 Tx date 2022-03-03 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$83,750
+250,000 vol $0.335 each |
||
| Filed 2022-03-17 17:30 Tx date 2022-03-03 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$83,750
+250,000 vol $0.335 each |
250,000 | |
| Filed 2022-03-17 17:29 Tx date 2022-02-03 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-17 17:28 Tx date 2022-02-03 |
$TELO
Telo Genomics Corp. |
McGlennen, Ronald C.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|